For those with “un-classified” diabetes at onset (N = 35), 11 persons were ultimately diagnosed with T1DM, with the majority of them receiving basal-bolus insulin treatment and only one person receiving a combination of basal-bolus insulin and OHAs. This evidence concerns the gene INS and diabetes mellitus.